Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

International Biobanking for Lung Cancer and COPD as the Future Resource for Clinical Protein Research

Fehniger, Thomas LU ; Végvári, Ákos LU ; Rezeli, Melinda LU orcid ; Döme, Balázs ; Timár, József and Marko-Varga, György LU (2013) In EuPA Open Proteomics 1. p.3-7
Abstract
Characterized tissue with pathological grading and blood samples as well as other biofluids forms the basis for all biobanks as a resource in modern life science. Biobanks are accessed to measure biological components that can be used to monitor the status of health and disease in individual samples and population groups. The biomarker diagnostics area, predicting drug efficacy, stratification of patient groups, can benefit from the continuous qualitative developments, where Proteomics can make a difference in lung cancer and COPD. This in turn can provide key treasures to novel drugs for personalized medicine in the future.
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Lung Cancer, COPD, Biobank, Pathology
in
EuPA Open Proteomics
volume
1
pages
3 - 7
publisher
Elsevier
external identifiers
  • scopus:84884583780
ISSN
2212-9685
DOI
10.1016/j.euprot.2013.04.001
language
English
LU publication?
yes
id
d53fe5c9-0a6c-4b85-9b80-e612707ddaf7 (old id 3411874)
date added to LUP
2016-04-01 13:49:09
date last changed
2023-09-03 05:33:50
@article{d53fe5c9-0a6c-4b85-9b80-e612707ddaf7,
  abstract     = {{Characterized tissue with pathological grading and blood samples as well as other biofluids forms the basis for all biobanks as a resource in modern life science. Biobanks are accessed to measure biological components that can be used to monitor the status of health and disease in individual samples and population groups. The biomarker diagnostics area, predicting drug efficacy, stratification of patient groups, can benefit from the continuous qualitative developments, where Proteomics can make a difference in lung cancer and COPD. This in turn can provide key treasures to novel drugs for personalized medicine in the future.}},
  author       = {{Fehniger, Thomas and Végvári, Ákos and Rezeli, Melinda and Döme, Balázs and Timár, József and Marko-Varga, György}},
  issn         = {{2212-9685}},
  keywords     = {{Lung Cancer; COPD; Biobank; Pathology}},
  language     = {{eng}},
  pages        = {{3--7}},
  publisher    = {{Elsevier}},
  series       = {{EuPA Open Proteomics}},
  title        = {{International Biobanking for Lung Cancer and COPD as the Future Resource for Clinical Protein Research}},
  url          = {{http://dx.doi.org/10.1016/j.euprot.2013.04.001}},
  doi          = {{10.1016/j.euprot.2013.04.001}},
  volume       = {{1}},
  year         = {{2013}},
}